Curis
CRIS
#11033
Rank
$6.05 M
Marketcap
$0.91
Share price
6.65%
Change (1 day)
-30.80%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2023 (TTM): -$10.00

According to Curis's latest financial reports the company's current EPS (TTM) is -$14.22. In 2022 the company made an earnings per share (EPS) of -$12.20 a decrease over its 2021 EPS that were of -$10.00.

EPS history for Curis from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$10.00-18.03%
2022-$12.2022%
2021-$10.00-25.37%
2020-$13.40-30.93%
2019-$19.40-2.02%
2018-$19.80-37.38%
2017-$31.62-29.73%
2016-$45.00-10%
2015-$50.00138.1%
2014-$21.0040%
2013-$15.00-25%
2012-$20.0066.67%
2011-$12.00-850%
2010$1.60-114.29%
2009-$11.20-26.07%
2008-$15.15-26.28%
2007-$20.558.44%
2006-$18.95-32.68%
2005-$28.15-3.76%
2004-$29.2562.95%
2003-$17.95-93.86%
2002-$292.2539.5%
2001-$209.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
$0.76-105.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$4.52-131.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-$0.36-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
$3.46-124.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-$4.35-69.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-$3.18-77.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-$3.44-75.81%๐Ÿ‡บ๐Ÿ‡ธ USA